For example, mutations in the speckle-type POZ protein (SPOP), a substrate recognition component of the E3 ubiquitin ligase, can disrupt normal AR ubiquitination, leading to increased AR protein stability and enhanced AR signaling, ultimately increasing resistance in prostate cancer cells [23]. This evidence concerns the gene SPOP and prostate carcinoma.